Clinical Research Cohort for Polycystic Ovary Syndrome

Official record

Identifier

NCT07739940

Recruiting locations

country

China

Interventions studied

Not provided in the official record

Lead sponsor

Guangdong Women and Children Hospital

Target enrolment

420 participants

Study type

OBSERVATIONAL

Phase

Not provided in the official record

Status

Active, not recruiting

First posted

Jul 31, 2026

Last updated on the registry

Jul 31, 2026

Age

16 Years – 45 Years

Sex

FEMALE

Study contact

No public contact is listed on the official record.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

I. Diagnostic Criteria: 2023 International Evidence-based Guidelines for the Assessment and Management of Polycystic Ovary Syndrome

II. Inclusion and Exclusion Criteria:

1. PCOS Group

   Inclusion Criteria:

   Meets the above PCOS diagnostic criteria; Voluntarily signs the informed consent form; Has complete baseline clinical data (including hormonal, metabolic, and ultrasound parameters).

   Exclusion Criteria:

   Other conditions causing hyperandrogenism or ovulatory dysfunction; Use of hormonal medications within 3 months; Concurrent severe cardiac, hepatic, or renal diseases; Mental disorders that preclude compliance with follow-up.
2. Control Group

Inclusion Criteria:

Age- and BMI-matched healthy females; Regular menstrual cycles (21-35 days); No clinical manifestations or biochemical evidence of hyperandrogenism.

Indexed under

Ovarian Cancer